Literature DB >> 19913485

Crystal structures of the N-terminal domains of cardiac and skeletal muscle ryanodine receptors: insights into disease mutations.

Paolo Antonio Lobo1, Filip Van Petegem.   

Abstract

Ryanodine receptors (RyRs) are channels governing the release of Ca(2+) from the sarcoplasmic or endoplasmic reticulum. They are required for the contraction of both skeletal (RyR1) and cardiac (RyR2) muscles. Mutations in both RyR1 and RyR2 have been associated with severe genetic disorders, but high-resolution data describing the disease variants in detail have been lacking. Here we present the crystal structures of the N-terminal domains of both RyR2 (1-217) and RyR1 (9-205) at 2.55 A and 2.9 A, respectively. The domains map in a hot spot region for disease mutations. Both structures consist of a core beta trefoil domain flanked by an alpha helix. Crystal structures of two RyR2 disease mutants, A77V (2.2 A) and V186M (1.7 A), show that the mutations cause distinct local changes in the surface of the protein. A RyR2 deletion mutant causes significant changes in the thermal stability. The disease positions highlight two putative binding interfaces required for normal RyR function.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913485     DOI: 10.1016/j.str.2009.08.016

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  49 in total

Review 1.  IP(3) receptors: toward understanding their activation.

Authors:  Colin W Taylor; Stephen C Tovey
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-10-27       Impact factor: 10.005

2.  The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule.

Authors:  Ching-Chieh Tung; Paolo A Lobo; Lynn Kimlicka; Filip Van Petegem
Journal:  Nature       Date:  2010-11-03       Impact factor: 49.962

3.  Single-particle cryo-EM of the ryanodine receptor channel in an aqueous environment.

Authors:  Mariah R Baker; Guizhen Fan; Irina I Serysheva
Journal:  Eur J Transl Myol       Date:  2015

4.  RYR1 and CACNA1S genetic variants identified with statin-associated muscle symptoms.

Authors:  Paul J Isackson; Jianxin Wang; Mohammad Zia; Paul Spurgeon; Adrian Levesque; Jonathan Bard; Smitha James; Norma Nowak; Tae Keun Lee; Georgirene D Vladutiu
Journal:  Pharmacogenomics       Date:  2018-10-16       Impact factor: 2.533

5.  Characterization of a novel mutation in the cardiac ryanodine receptor that results in catecholaminergic polymorphic ventricular tachycardia.

Authors:  Dawei Jiang; Peter P Jones; Darryl R Davis; Robert Gow; Martin S Green; David H Birnie; S R Wayne Chen; Michael H Gollob
Journal:  Channels (Austin)       Date:  2010-07-14       Impact factor: 2.581

Review 6.  Ryanodine receptors: structure and function.

Authors:  Filip Van Petegem
Journal:  J Biol Chem       Date:  2012-07-20       Impact factor: 5.157

Review 7.  TRP channels as sensors of oxygen availability.

Authors:  Tomohiro Numata; Nozomi Ogawa; Nobuaki Takahashi; Yasuo Mori
Journal:  Pflugers Arch       Date:  2013-02-17       Impact factor: 3.657

8.  Abnormal termination of Ca2+ release is a common defect of RyR2 mutations associated with cardiomyopathies.

Authors:  Yijun Tang; Xixi Tian; Ruiwu Wang; Michael Fill; S R Wayne Chen
Journal:  Circ Res       Date:  2012-02-28       Impact factor: 17.367

9.  Roles of the NH2-terminal domains of cardiac ryanodine receptor in Ca2+ release activation and termination.

Authors:  Yingjie Liu; Bo Sun; Zhichao Xiao; Ruiwu Wang; Wenting Guo; Joe Z Zhang; Tao Mi; Yundi Wang; Peter P Jones; Filip Van Petegem; S R Wayne Chen
Journal:  J Biol Chem       Date:  2015-01-27       Impact factor: 5.157

10.  Bioinformatic mapping and production of recombinant N-terminal domains of human cardiac ryanodine receptor 2.

Authors:  Vladena Bauerová-Hlinková; Eva Hostinová; Juraj Gasperík; Konrad Beck; Lubomír Borko; F Anthony Lai; Alexandra Zahradníková; Jozef Sevcík
Journal:  Protein Expr Purif       Date:  2010-01-04       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.